mhurhangee/patent-ind-claim-en huggingface dataset:
A transceiver of a user equipment , the transceiver comprising: a receiving stage ; a frontend channel estimator ; a frontend channel equalizer ; a backend channel estimator ; and a backend channel equalizer ; wherein the receiving stage is configured to receive an inbound signal from a Shared User Equipment-Side Distributed Antenna Component , wherein the Shared User Equipment-Side Distributed Antenna Component enables a relay communication comprising a frontend communication using extremely-high frequencies between the Shared User Equipment-Side Distributed Antenna Component and the user equipment , and a backend communication using ultra-high frequencies between a base station and the Shared User Equipment-Side Distributed Antenna Component , wherein the inbound signal comprises a data portion , a backend control portion provided by the base station and a frontend control portion , the frontend control portion comprising a frontend evaluation signal ; wherein the frontend channel estimator is configured to perform a channel estimation based on the frontend evaluation signal ; wherein the frontend channel equalizer is configured to equalize distortions, caused by using the extremely-high frequencies, based on the channel estimation of the frontend channel estimator ; wherein the backend channel estimator is configured to perform a channel estimation based on the backend control portion ; and wherein the backend channel equalizer is configured to equalize distortions, caused by using the ultra-high frequencies, based on the channel estimation of the backend channel estimator . a receiving stage ; a frontend channel estimator ; a frontend channel equalizer ; a backend channel estimator ; and a backend channel equalizer ; wherein the receiving stage is configured to receive an inbound signal from a Shared User Equipment-Side Distributed Antenna Component , wherein the Shared User Equipment-Side Distributed Antenna Component enables a relay communication comprising a frontend communication using extremely-high frequencies between the Shared User Equipment-Side Distributed Antenna Component and the user equipment , and a backend communication using ultra-high frequencies between a base station and the Shared User Equipment-Side Distributed Antenna Component , wherein the inbound signal comprises a data portion , a backend control portion provided by the base station and a frontend control portion , the frontend control portion comprising a frontend evaluation signal ; wherein the frontend channel estimator is configured to perform a channel estimation based on the frontend evaluation signal ; wherein the frontend channel equalizer is configured to equalize distortions, caused by using the extremely-high frequencies, based on the channel estimation of the frontend channel estimator ; wherein the backend channel estimator is configured to perform a channel estimation based on the backend control portion ; and wherein the backend channel equalizer is configured to equalize distortions, caused by using the ultra-high frequencies, based on the channel estimation of the backend channel estimator .
A series of alloyed semiconductor quantum dots, wherein each alloyed semiconductor quantum dot of the series comprises an alloy of at least two semiconductors and has a homogeneous composition, wherein at least one of the alloyed semiconductor quantum dots of the series is characterized by a band gap energy that is non-linearly related to the molar ratio of the at least two semiconductors, wherein each of the alloyed semiconductor quantum dots of the series comprises the same alloy, but varies in molar ratio of the at least two semiconductors, wherein the alloy comprises CdSeTe and has a molecular formula CdSe 1-x Te x , wherein the alloy comprises CdSSe and has a molecular formula CdS 1-x Se x , the alloy comprises CdSTe and has a molecular formula CdS 1-x Te x , the alloy comprises ZnSeTe and has a molecular formula ZnSe 1-x Te x , the alloy comprises ZnCdTe and has a molecular formula Zn 1-x Cd x Te, the alloy comprises CdHgS and has a molecular formula Cd 1-x Hg x S, the alloy comprises HgCdTe and has a molecular formula HgCdTe, the alloy comprises InGaAs and has a molecular formula InGaAs, the alloy comprises GaAlAs and has a molecular formula GaAIAs, or the alloy comprises InGaN and has a molecular formula InGaN, wherein x is any fraction between 0 and 1, wherein each of the quantum dots is conjugated to a biological agent, characterized in that the size of each quantum dot is within about 5% of the size of the average-sized quantum dot.
A method for predicting disease progression or therapy response in a Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patient, comprising the steps of: - determining in a sample of a CIDP patient the concentration of serum neurofilament light chain (sNfL), - comparing the determined value with a reference value, wherein an increased value compared to a reference value of individuals without disease progression is indicative for disease progression or is indicative for a need to switch therapy, and/or - wherein a decreased value compared to a reference value of individuals without disease progression is indicative for responding to a therapy, or - comparing the determined value with a median value of a group of patients comprising both patients likely to develop disease progression and patients likely not to develop disease progression, - wherein an value of sNfL above the median value of the group is indicative for disease progression or is indicative for a need to switch therapy, and/or - wherein a value of sNfL below the median value is indicative for responding to a therapy. - determining in a sample of a CIDP patient the concentration of serum neurofilament light chain (sNfL), - comparing the determined value with a reference value, wherein an increased value compared to a reference value of individuals without disease progression is indicative for disease progression or is indicative for a need to switch therapy, and/or - wherein a decreased value compared to a reference value of individuals without disease progression is indicative for responding to a therapy, or - comparing the determined value with a median value of a group of patients comprising both patients likely to develop disease progression and patients likely not to develop disease progression, - wherein an value of sNfL above the median value of the group is indicative for disease progression or is indicative for a need to switch therapy, and/or - wherein a value of sNfL below the median value is indicative for responding to a therapy.
An ingestible device, comprising: an integrated circuit component comprising a modulator; and a first power source including: a first material associated with the integrated circuit component; and a second material different from the first material; wherein: the second material is associated with the integrated circuit component; the first material and the second material are collectively configured to provide a voltage potential difference when in contact with a conductive fluid of a user ingesting the ingestible device and, upon contact with the conductive fluid, provide power to the integrated circuit component; the integrated circuit component is electrically connected to the first material and the second material; the device further comprising a conductive antenna coupled to the modulator, wherein the modulator is configured to modulate a signal associated with at least one of data or the conductive antenna to generate a detectable signal at least partially defined by current flow that extends through the conductive fluid; and the modulator is configured to be powered by a second power source not physically coupled to the modulator in addition to the first power source. an integrated circuit component comprising a modulator; and a first power source including: a first material associated with the integrated circuit component; and a second material different from the first material; a first material associated with the integrated circuit component; and a second material different from the first material; wherein: the second material is associated with the integrated circuit component; the first material and the second material are collectively configured to provide a voltage potential difference when in contact with a conductive fluid of a user ingesting the ingestible device and, upon contact with the conductive fluid, provide power to the integrated circuit component; the integrated circuit component is electrically connected to the first material and the second material; the device further comprising a conductive antenna coupled to the modulator, the second material is associated with the integrated circuit component; the first material and the second material are collectively configured to provide a voltage potential difference when in contact with a conductive fluid of a user ingesting the ingestible device and, upon contact with the conductive fluid, provide power to the integrated circuit component; the integrated circuit component is electrically connected to the first material and the second material; the device further comprising a conductive antenna coupled to the modulator, wherein the modulator is configured to modulate a signal associated with at least one of data or the conductive antenna to generate a detectable signal at least partially defined by current flow that extends through the conductive fluid; and the modulator is configured to be powered by a second power source not physically coupled to the modulator in addition to the first power source.
A thrombectomy device comprising: an interventional element configured to be advanced intravascularly to a treatment site in a corporeal lumen and to engage a thrombus therein, wherein the interventional element possesses an inner conductive material and an overlying material that has a lower electrical conductivity than the inner conductive material, characterized by the overlying material having a thickness gradient that decreases from a first thickness in a proximal portion of the interventional element to a second non-zero thickness in a distal portion of the interventional element such that a surface electrical conductivity of the interventional element has a gradient that increases from the proximal portion of the interventional element to the distal portion of the interventional element , wherein the surface electrical conductivity is greater than zero in the proximal portion. an interventional element configured to be advanced intravascularly to a treatment site in a corporeal lumen and to engage a thrombus therein, wherein the interventional element possesses an inner conductive material and an overlying material that has a lower electrical conductivity than the inner conductive material, characterized by the overlying material having a thickness gradient that decreases from a first thickness in a proximal portion of the interventional element to a second non-zero thickness in a distal portion of the interventional element such that a surface electrical conductivity of the interventional element has a gradient that increases from the proximal portion of the interventional element to the distal portion of the interventional element , wherein the surface electrical conductivity is greater than zero in the proximal portion.
Fixed window for a railway rolling stock car , intended to cover an opening formed in the bodywork of the stock car , which window comprises a first, so-called fixing frame provided to be secured at the border of the opening and a glass pane comprising a protective glazed main part and which is disposed on the fixing frame covering the opening , wherein the window comprises a second, so-called tight-fitting frame disposed on the glass pane , which glass pane comprises at least one peripheral lug which protrudes from the peripheral edge of its glazed main part , and which is fitted tightly between the fixing frame and the tight-fitting frame that are secured together.
A seat pad comprising: an air permeable member having a ventilation function with an outside; wherein the seat pad is integrally foam molded using a foamed resin material, characterized in that the seat pad is molded in a state where the air permeable member is introduced; and the seat pad has a surface of the air permeable member projecting with respect to a surface of the seat pad located adjacent to the air permeable member , and the air permeable member that is compressed via a covering member is filled inside an opening of the seat pad, wherein the air permeable member has high air permeability compared with the seat pad . an air permeable member having a ventilation function with an outside; wherein the seat pad is integrally foam molded using a foamed resin material, characterized in that the seat pad is molded in a state where the air permeable member is introduced; and the seat pad has a surface of the air permeable member projecting with respect to a surface of the seat pad located adjacent to the air permeable member , and the air permeable member that is compressed via a covering member is filled inside an opening of the seat pad, wherein the air permeable member has high air permeability compared with the seat pad .
A method of detecting a DNA repair-associated gene which responds to low-dose radiation, comprising the steps of: exposing AKR/J mice, as a thymus cancer model, and normal ICR mice in a low-dose radiation environment; collecting thymuses from the AKR/J thymus cancer mouse model and the normal ICR mice which have been exposed at the step ; analyzing genes in the thymuses collected at the step ; detecting, among the genes analyzed at the step , DNA repair-associated genes expressed commonly or differentially in the AKR/J thymus cancer mouse model and the normal ICR mice; and amplifying the genes detected at the step and measuring an expression level thereof, wherein at the step , the DNA repair-associated genes are Cyp11a1, Rnd3 and Plxnc1 genes, and wherein, at the step , the low-dose radiation is delivered at a dose rate of 0.7 mGy/h. exposing AKR/J mice, as a thymus cancer model, and normal ICR mice in a low-dose radiation environment; collecting thymuses from the AKR/J thymus cancer mouse model and the normal ICR mice which have been exposed at the step ; analyzing genes in the thymuses collected at the step ; detecting, among the genes analyzed at the step , DNA repair-associated genes expressed commonly or differentially in the AKR/J thymus cancer mouse model and the normal ICR mice; and amplifying the genes detected at the step and measuring an expression level thereof, wherein at the step , the DNA repair-associated genes are Cyp11a1, Rnd3 and Plxnc1 genes, and wherein, at the step , the low-dose radiation is delivered at a dose rate of 0.7 mGy/h.
An overvoltage protection system for a generator of a power generating system, comprising: a generator control relay (GCR) controlling a conduction path between a generator control unit (GCU) and a generator exciter field ; a flyback impedance in parallel communication with the generator exciter field, the flyback impedance being configured to dissipate energy from the generator exciter field in response to opening of the conduction path; a gate drive configured to open and close the GCR; and an overvoltage prevention unit in signal communication with the gate drive, the overvoltage prevention unit being configured to monitor a voltage and a current associated with the generator and selectively output a control signal to the gate drive to open and close the conduction path controlled by the GCR in response to the monitored voltage and current, characterized in that the overvoltage prevention unit is configured to output the control signal selective to both whether an overvoltage fault exists and whether an overcurrent fault exists. a generator control relay (GCR) controlling a conduction path between a generator control unit (GCU) and a generator exciter field ; a flyback impedance in parallel communication with the generator exciter field, the flyback impedance being configured to dissipate energy from the generator exciter field in response to opening of the conduction path; a gate drive configured to open and close the GCR; and an overvoltage prevention unit in signal communication with the gate drive, the overvoltage prevention unit being configured to monitor a voltage and a current associated with the generator and selectively output a control signal to the gate drive to open and close the conduction path controlled by the GCR in response to the monitored voltage and current, characterized in that the overvoltage prevention unit is configured to output the control signal selective to both whether an overvoltage fault exists and whether an overcurrent fault exists.
An injector device comprising: a container and a plunger that is movable into the container to dispense medicament during operation of the injector device; a biasing member arranged to push the plunger into the container during operation of the device; a latch arranged to hold the plunger in an initial position where the biasing member is under compression prior to operation of the injector device, wherein the plunger is configured to be rotated to disengage the latch; a switch arranged to interact with a structural element of the plunger to detect movement of the plunger during operation of the injector device, wherein the switch is arranged to be aligned with the structural element of the plunger after the plunger has been rotated; and a needle sleeve slidably mounted in the injector device and arranged such that during use the needle sleeve slides into engagement with the plunger to cause the plunger to rotate and disengage the latch. a container and a plunger that is movable into the container to dispense medicament during operation of the injector device; a biasing member arranged to push the plunger into the container during operation of the device; a latch arranged to hold the plunger in an initial position where the biasing member is under compression prior to operation of the injector device, wherein the plunger is configured to be rotated to disengage the latch; a switch arranged to interact with a structural element of the plunger to detect movement of the plunger during operation of the injector device, wherein the switch is arranged to be aligned with the structural element of the plunger after the plunger has been rotated; and a needle sleeve slidably mounted in the injector device and arranged such that during use the needle sleeve slides into engagement with the plunger to cause the plunger to rotate and disengage the latch.
A method for paging a user equipment, UE, in a communication system , wherein the communication system comprises multiple radio access networks RANs which are connected to an adaptation function that abstracts RAN functions into a form similar to an application programming interface for a software defined network and whereby the software defined network comprises a virtual mobility function, VMM, which is responsible for paging the UE across multiple RANs without knowing on which RAN the UE is camped, wherein the VMM maintains a list of RANs which includes one or more RANs that have served the UE in the past, or for which an attachment status of the UE in the VMM is otherwise valid, whereby the attachment status comprises a list of RANS that have served or may potentially serve the UE and/or one or more RANs that may serve the UE, the method comprising: receiving , by the adaptation function from the VMM, a generic page indication for the UE, the generic page indication including the list of RANs; selecting , by the adaptation function, a subset of the list of RANs; sending , by the adaptation function, a RAN-specific page indication for each RAN in the subset of the list of RANs; receiving , by the adaptation function, a first RAN-specific page response associated with the UE; and sending , by the adaptation function to the VMM, a generic page response corresponding to the first RAN-specific page response; wherein at least two RANs in the list of RANs operate using distinct RATs. receiving , by the adaptation function from the VMM, a generic page indication for the UE, the generic page indication including the list of RANs; selecting , by the adaptation function, a subset of the list of RANs; sending , by the adaptation function, a RAN-specific page indication for each RAN in the subset of the list of RANs; receiving , by the adaptation function, a first RAN-specific page response associated with the UE; and sending , by the adaptation function to the VMM, a generic page response corresponding to the first RAN-specific page response; wherein at least two RANs in the list of RANs operate using distinct RATs.
User equipment, wherein the equipment comprises: a determining unit , configured to: when it is determined that user equipment in an idle state, trigger cell reselection measurement and determine an available radio technology type according to obtained information about an access supportable radio technology type or information about an access prohibited radio access type; and a search unit , configured to search, by cell reselection measurement, according to the available radio technology type determined by the determining unit, for an available network corresponding to the available radio technology type, wherein the available network is used by the user equipment to process data; wherein when performing cell reselection measurement, the user equipment is configured to perform network search and cell measurement only on a network corresponding to the access supportable radio technology type so as to avoid that the user equipment fails to register with a network after cell reselection is performed, and wherein the user equipment is further configured to determine, according to the measurement result, whether to reselect a cell. a determining unit , configured to: when it is determined that user equipment in an idle state, trigger cell reselection measurement and determine an available radio technology type according to obtained information about an access supportable radio technology type or information about an access prohibited radio access type; and a search unit , configured to search, by cell reselection measurement, according to the available radio technology type determined by the determining unit, for an available network corresponding to the available radio technology type, wherein the available network is used by the user equipment to process data; wherein when performing cell reselection measurement, the user equipment is configured to perform network search and cell measurement only on a network corresponding to the access supportable radio technology type so as to avoid that the user equipment fails to register with a network after cell reselection is performed, and wherein the user equipment is further configured to determine, according to the measurement result, whether to reselect a cell.